Literature DB >> 36074234

Bioinformatic Analysis Divulged Novel Prognostic Circulating MicroRNAs and Their Potential Target Genes in Breast Cancer.

Babak Pourgholamali1, Behnoush Sohrabi2, Mandana Salbi3, Sanaz Akbari4, Iman Rastan5, Masoud Sayaf6, Abduladheem Turki Jalil7, Mustafa M Kadhim8,9, Roghayeh Sheervalilou10, Nazanin Mehrzad11.   

Abstract

Breast cancer (BC) is both an inherited and environmental-based disease which is the leading cause of death among women. Early detection of BC can prevent invasion and metastasis in patients. Currently, researchers endeavor to find non-invasive biological markers from body fluids. Circulating non-coding RNAs such as microRNAs (miRNAs) can potentially be valuable prognostic and detective biomarkers. To identify novel miRNA-based biomarkers, we utilized bioinformatic tools. To reach this goal, the miRNA expression profiles of GSE31309, GSE 44,281, GSE98181, and GSE118782 were analyzed through a limma package of R. Target gene prediction of differentially expressed miRNAs, called differentially expressed miRNAs (DEMs), between samples of healthy individuals and BC patients was implemented through Multimir package of R. Functional enrichment analysis of predicted target genes through Enrich R (online database) revealed that most of the genes are enriched in the mitochondrial outer membrane for cellular component, intrinsic apoptotic signaling regulations for biological processes, transcription co-receptor activity for molecular functions, and dopaminergic synapse pathway. Furthermore, our survival analysis results revealed that miR-29c and mir-361 have the potential to serve as prognostic biomarkers.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioinformatics; Breast cancer (BC); Circulating microRNAs (miRNAs); Differentially expressed miRNAs (DEMs); Prognostic; Target genes

Year:  2022        PMID: 36074234     DOI: 10.1007/s12010-022-04151-9

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   3.094


  4 in total

1.  miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.

Authors:  Xinping Xie; Yuxiu Huang; Lihong Chen; Jinhua Wang
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

2.  Levisticum Officinale Extract Triggers Apoptosis and Down-Regulates ZNF703 Gene Expression in Breast Cancer Cell Lines.

Authors:  Fatemeh Mollashahee-Kohkan; Ramin Saravani; Tahereh Khalili; Hamidreza Galavi; Saman Sargazi
Journal:  Rep Biochem Mol Biol       Date:  2019-07

Review 3.  Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy.

Authors:  Iqra Fatima; Abbas Rahdar; Saman Sargazi; Mahmood Barani; Mohadeseh Hassanisaadi; Vijay Kumar Thakur
Journal:  J Funct Biomater       Date:  2021-12-16

Review 4.  Epidemiology of breast cancer, a paradigm of the "common soil" hypothesis.

Authors:  Licia Iacoviello; Marialaura Bonaccio; Giovanni de Gaetano; Maria Benedetta Donati
Journal:  Semin Cancer Biol       Date:  2020-02-20       Impact factor: 15.707

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.